I think one of the problems is that the Insto's/Funds/Brokers are using traditional tools to analyse A2M's health and value in a market place that is not traditional in any way.
When we look at the beveridge market around the world, it is commodity producers that are losing to competitors that are 'selling' a niche market product with some sort of health benefit, i.e. coconut water anyone? Customers do not see the value of A1 milk anymore and go for lowest price, this isn a market that sell 'milk' from almost everything, fruit, nuts, cereals etc Even coke has been moved into the commodity area as their sales start dropping and people look for healthier alternatives. Mass beer makers are losing to 'craft' beer makers, bulk spirits to high end and craft spirit makers.
Mothers in China want the best for their kids, they remember the not so good times, (or the grandparents do), they want their kids to be smart and try to give them every advantage they can. A2 is perceived as one of those advantages, overseas education as another. Mothers in China will continue to buy A2M and recommend it (or boast about their ability to buy it) until something takes that trust away.
I just don't think Insto's/Funds/Brokers fully comprehend A2M and it's product, they just don't get it, so they put it in the same box as other commodity dairy companies, none of which are doing very well.
As an example, look at the Visual below from 'Simply Wallstreet', according to this visual the value of A2 shares is low, even though the future prospects appear bright. As a contrast look at Amazon visual below A2, according to traditional analysis its a dismal company not worth investing in at all.
Chart update, page-10960
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.81 |
Change
-0.090(1.84%) |
Mkt cap ! $3.482B |
Open | High | Low | Value | Volume |
$4.92 | $4.95 | $4.80 | $8.716M | 1.802M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10795 | $4.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.83 | 5662 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10795 | 4.810 |
14 | 50515 | 4.800 |
10 | 88280 | 4.790 |
8 | 128503 | 4.780 |
4 | 31267 | 4.770 |
Price($) | Vol. | No. |
---|---|---|
4.830 | 5662 | 1 |
4.840 | 6237 | 1 |
4.850 | 50303 | 2 |
4.890 | 15000 | 2 |
4.930 | 15000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online